Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors. (Q41228724)
Jump to navigation
Jump to search
scientific article published on 14 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors. |
scientific article published on 14 May 2015 |
Statements
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors (English)
Amita Patnaik
S Peter Kang
Drew Rasco
Kyriakos P Papadopoulos
Jeroen Elassaiss-Schaap
Muralidhar Beeram
Ronald Drengler
Cong Chen
Lon Smith
Guillermo Espino
Kevin Gergich
Liliana Delgado
Jill A Lindia
Xiaoyun Nicole Li
Robert H Pierce
Jennifer H Yearley
Dianna Wu
Omar Laterza
Manfred Lehnert
Robert Iannone
Anthony W Tolcher